Patheon announced that Wesley P. Wheeler, the company's chief executive officer and president, has left the company. Peter Bigelow has been named interim chief executive officer.
Cellectis and Harvard Apparatus signed a license agreement that grants Harvard Apparatus the worldwide exclusive right to manufacture and sell, for research use, a line of electroporation-based instruments.
A panel of federal health experts rejected the use of two drugs from Merck and GlaxoSmithKline to prevent prostate cancer, saying the drugs could actually raise the risk of the most serious types of tumors.
Momenta Pharmaceuticals, Inc. announced that it has sued Teva Pharmaceutical Industries Ltd. in the United States District Court for the District of Massachusetts for infringement of two Momenta patents.
A new finding offers insight into a new treatment avenue for two painful inflammatory diseases: Crohn’s Disease and sarcoidosis.
Valeant Pharmaceuticals International Inc. and GlaxoSmithKline PLC said that the Food and Drug Administration (FDA) did not approve their epilepsy drug candidate ezogabine.
Drug developer Pfizer Inc. said December 2 it received European regulatory approval for Sutent as a treatment for a rare type of pancreatic tumors.
QR Pharma, Inc. announced that the FDA has accepted the Investigational New Drug application to begin human clinical trials and evaluate the safety and efficacy of the company’s second product, bisnorcymserine (BNC).
Zogenix, Inc. and Desitin Pharmaceuticals GmbH announced that the Danish Medicines Agency of Denmark has approved the Marketing Authorization Application for SUMAVEL DosePro Needle-Free Delivery System.
Integrated DNA Technologies, a leader in oligonucleotide synthesis, and Rensselaer Polytechnic Institute announced the launch of the UNAFold secondary structure prediction software at IDT.
A robust, off-the-shelf solution for screening Human Retinoic Acid Receptor Gamma (RAR?) is now available from INDIGO Biosciences. INDIGO Nuclear Receptor Assay Kits go from freezer to data in 24 hours with minimal hands-on time.
Thermo Fisher Scientific Inc. offers a ‘guide to good washing practice,’ an online guide is designed as a step-by-step tool, providing detailed guidance on obtaining secure and reliable performance with every use of the its Wellwash microplate washers.
CYTOO Cell Architects introduced CYTOOplates 96 for pharma, biotech and academic screening center customers employing high content cell-based assays for research, drug safety, and drug screening applications.
Aushon BioSystems, Inc. has partnered with LightArray Biotech Company, Ltd., to provide Aushon’s suite of multiplex biomarker products and services to pharmaceutical, biotechnical, and academic research institutions located in mainland China.
Advanced Clinical, a leader in pharmaceutical development, announced an addition to its leadership team: Mark Lanfear has been hired as Vice President, Clinical Operations to lead Advanced Clinical in its expansion of service offerings for 2011.